Molecular Imaging of Membrane Transporters’ Activity in Cancer: a Picture is Worth a Thousand Tubes
Journal Title: The AAPS Journal - Year 2015, Vol 17, Issue 4
Abstract
Molecular imaging allows the non-invasive assessment of membrane transporter expression and function in living subjects. Such technologies have the potential to become diagnostic and prognostic tools, allowing detection, localization, and prediction of response of tumors and their metastases to therapy. Beyond tumors, imaging can also help understand the role of transporters in adverse drug effects and drug clearance. Here, we review molecular imaging technologies that monitor transporter-mediated processes. We emphasize emerging probe substrates and potential clinical applications of imaging the function of membrane transporters in cancer.
Authors and Affiliations
Aniv Mann, Inessa Semenenko, Michal Meir, Sara Eyal
Keywords
Related Articles
- EP ID EP680965
- DOI 10.1208/s12248-015-9752-6
- Views 77
- Downloads 0
Indolealkylamines: Biotransformations and Potential Drug–Drug Interactions
Indolealkylamine (IAA) drugs are 5-hydroxytryptamine (5-HT or serotonin) analogs that mainly act on the serotonin system. Some IAAs are clinically utilized for antimigraine therapy, whereas other substances are notable a...
Effects of protein aggregates: An immunologic perspective
The capacity of protein aggregates to enhance immune responses to the monomeric form of the protein has been known for over a half-century. Despite the clear connection between protein aggregates and antibody mediated ad...
A Sensitivity Analysis of the Modified Chi-square Ratio Statistic for Equivalence Testing of Aerodynamic Particle Size Distribution
The online version of this article (doi:10.1208/s12248-013-9453-y) contains supplementary material, which is available to authorized users.
Emerging Technologies to Increase Ligand Binding Assay Sensitivity
Ligand binding assays (LBAs) have been the method of choice for protein analyte measurements for more than four decades. Over the years, LBA methods have improved in sensitivity and achieved larger dynamic ranges by usin...
Strategic Approaches to Optimizing Peptide ADME Properties
Development of peptide drugs is challenging but also quite rewarding. Five blockbuster peptide drugs are currently on the market, and six new peptides received first marketing approval as new molecular entities in 2012....